---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-035076"
form_type: "8-K"
ticker: "HEPA"
cik: "0001583771"
company_name: "Hepion Pharmaceuticals, Inc."
filed_at: "2024-09-05T23:59:59+00:00"
generated_at: "2026-05-31T06:15:04.985517+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Hepion Pharmaceuticals receives Nasdaq deficiency notice for bid price below $1.00

## Summary
- Notice received Sept. 3, 2024; bid price below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until March 3, 2025, to regain compliance.
- To regain compliance, closing bid must be ≥$1.00 for at least 10 consecutive business days.
- If not compliant, may qualify for a second 180-day period; otherwise Nasdaq will delist.
- Common stock continues trading on Nasdaq under symbol HEPA.

## SEC filing metadata
- accession: 0001493152-24-035076
- form_type: 8-K
- ticker: HEPA
- cik: 0001583771
- company_name: Hepion Pharmaceuticals, Inc.
- filed_at: 2024-09-05T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583771/000149315224035076/0001493152-24-035076-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583771/000149315224035076/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-035076
- JSON: https://secwatch.observer/filing/0001493152-24-035076.json
- Plain text: https://secwatch.observer/filing/0001493152-24-035076.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.